The stock of biotechnology firm Intellia Therapeutics has experienced a severe downturn after US regulators imposed a ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies ...

Intellia Therapeutics (NASDAQ:NTLA) stock tumbled 50% Monday after the company announced it has temporarily paused patient dosing and screening for its Phase 3 clinical trials of nex-z due to a ...

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

Read on to learn why.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest ...

CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

FDA discussions around accelerated approval pathways now enable pooling clinical data to expedite biologics licenses for gene therapies, signaling regulatory momentum that favors early entrants ...

This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock ...

Detailed price information for Spotify Technology S.A. (SPOT-N) from The Globe and Mail including charting and trades.

An analyst enacted a rare double downgrade on the stock. He now feels it rates only a sell. Well before market open, Aletheia Capital's Nirgunan Tiruchelvam pushed his Jumia recommendation two steps ...

The solar specialist was a favorite subject of analysts recently. A total of four of them changed their price targets on the stock. No less than four pundits tracking the fortunes of the solar company ...